U.S. stock futures are showing mixed to slightly higher movements this Tuesday, December 23, 2025, as investors brace for a flurry of delayed economic data and navigate a holiday-shortened trading week. The market's cautious tone comes after three consecutive sessions of gains for major indexes, with the S&P 500 (SPX) hovering just 0.3% shy of its all-time closing high. Thin trading volumes are expected ahead of the Christmas Eve early close on Wednesday and the Christmas Day market holiday on Thursday.
Premarket Trading Activity and Futures Movements
As of early Tuesday, stock futures indicate a relatively subdued start to the day. Dow Jones Industrial Average (DJIA) futures were marginally higher, up 0.14%. S&P 500 (SPX) futures also edged up by 0.14%, while Nasdaq 100 (NDX) futures saw a slight increase of 0.07%. Some reports, however, indicated futures were near flat or slightly lower earlier in the morning, with S&P 500 E-minis up 0.04%, Nasdaq 100 E-minis up 0.06%, and Dow E-minis up 1 point. This premarket activity reflects a market positioning itself ahead of key economic reports, with a continued focus on expectations for interest rate cuts in 2026 following recent inflation readings. Gold and silver futures continued their remarkable rally, hitting new all-time highs for the second consecutive day, with gold futures (GC=F) trading near $4,460 per ounce and silver futures (SI=F) around $68.80 per ounce.
Current Performance of Major Market Indexes
Monday's trading saw all three major U.S. stock indexes close in positive territory, extending their winning streak to three sessions. The S&P 500 (SPX) advanced 0.6% to close at 6,878.49. The Dow Jones Industrial Average (DJIA) gained 0.5%, adding 227.79 points to finish at 48,362.68. The tech-heavy Nasdaq Composite (IXIC) also rose 0.5%, closing at 23,428.83. The strength was broad, with technology companies, particularly those involved in artificial intelligence (AI), continuing to drive market sentiment. Smaller company stocks also performed well, with the Russell 2000 index outpacing other major indexes with a 1.2% gain.
Important Upcoming Market Events
Today's trading session is heavily influenced by the release of several significant economic indicators, many of which were delayed. Investors are keenly awaiting the final revision of the third-quarter 2025 Gross Domestic Product (GDP) report, expected to show the U.S. economy grew at an annualized rate of 4.3% in the third quarter, surpassing the 3.2% median forecast. This robust growth figure follows a 3.8% increase in the second quarter.
Additionally, the December Consumer Confidence data from the Conference Board will be closely watched at 10:00 AM ET. This reading is crucial for gauging consumer sentiment, especially concerning higher-income versus lower-income households amidst elevated prices. Other delayed reports due today include October Durable Goods Orders and November Industrial Production. Any unexpected weakness in these data points could reinforce expectations for Federal Reserve interest rate cuts in 2026.
The U.S. stock market will observe special holiday hours this week, closing early at 1:00 PM ET on Wednesday, December 24th, for Christmas Eve and remaining closed all day on Thursday, December 25th, for Christmas Day. Markets will reopen for regular trading on Friday, December 26th.
Major Stock News and Corporate Announcements
Several major companies are in the spotlight today:
- Novo Nordisk (NVO): Shares of the Danish drugmaker surged approximately 8% in premarket trading after the U.S. Food and Drug Administration (FDA) approved its Wegovy pill (once-daily oral semaglutide 25 mg) for weight reduction and to reduce the risk of major adverse cardiovascular events. This approval gives Novo Nordisk a significant advantage over its rival, Eli Lilly (LLY), whose weight-loss pill is anticipated for approval in Q1 2026. Eli Lilly shares, in contrast, slipped 0.7% in premarket trading. Novo Nordisk expects to launch the product in the U.S. in early January.
- Warner Bros. Discovery (WBD) / Netflix (NFLX) / Paramount Global (PARA): The takeover battle for Warner Bros. Discovery continues to draw attention. Paramount Skydance (PARA) reportedly sweetened its hostile takeover bid for Warner Bros. Discovery with an “irrevocable personal guarantee” from Larry Ellison, founder of Oracle (ORCL), backing the deal with billions of dollars. Warner Bros. Discovery shares rose 3.5% on Monday, while Netflix fell 1.2%.
- Huntington Ingalls Industries (HII): The shipmaker saw its shares jump more than 4% in premarket trading following news that the Trump administration plans to build a new battleship class named after the President.
- Gossamer Bio (GOSS): Shares of the biotech company surged 9.59% in premarket trading, marking one of the steepest intraday gains in recent months. This rise is attributed to renewed investor confidence in biotech innovation and speculative positioning ahead of potential catalysts in late-stage pipeline developments.
- Micron Technology (MU), Oracle (ORCL), and Nvidia (NVDA): These technology giants, which saw gains of 4%, 3.2%, and 1.5% respectively on Monday, were trading slightly lower in premarket on Tuesday, down less than 1%.
- ZIM Integrated Shipping Services (ZIM): The company's shares climbed nearly 10% before the open after announcing it is evaluating acquisition proposals, reviving takeover speculation.
- Space-related stocks: Companies like Intuitive Machines (LUNR) and Firefly Aerospace (FLY) are experiencing pressure, with Intuitive Machines down about 5% in premarket trading after a strong three-day run.
Conclusion
As the U.S. stock market heads into the final days of 2025, investors are balancing holiday-thinned trading with crucial economic data releases. The "Santa Claus Rally," a historical trend of gains in the last five trading days of the year and the first two of the next, is a topic of discussion among strategists. While futures show a cautious optimism, the strength of the U.S. economy, as indicated by the robust Q3 GDP figures, and the ongoing developments in corporate news, particularly in the pharmaceutical and technology sectors, will continue to shape market direction. The Federal Reserve's stance on interest rates, heavily influenced by incoming economic data, remains a central theme for market participants looking ahead to 2026.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.